Where DNA Breaks
Our Insight Begins

Welcome to intoDNA, the pioneering DNA quality diagnostics company transforming DNA damage detection through the revolutionary technology, STRIDE™.

Leverage STRIDE™ through our end-to-end service for precision biomarker discovery and informed decision-making in targeted therapeutics development and patient selection.
hero image

Where DNA Breaks
Our Insight Begins

Welcome to intoDNA, the pioneering DNA quality diagnostics company transforming DNA damage detection through the revolutionary technology, STRIDE™.

Leverage STRIDE™ through our end-to-end service for precision biomarker discovery and informed decision-making in targeted therapeutics development and patient selection.

GET TO KNOW OUR PLATFORM

STRIDE™ Spotlight

image
icon

Direct

The technology directly detects free DNA ends in situ

icon

Quantitative

Automated and objective quantification of fluorescent foci by in-house built AI algorithms

icon

Compatible

Applicable with various types of biological material, including patient-derived tissue samples

icon

Sensitive

Reliable measurement of DNA damage at individual lesion level

icon

Specific

Selective detection of single-, double-, or repair protein-associated DNA breaks

intoDNA as a Partner

intodna icon 1

Expertise


STRIDE™, powered by intoDNA’s expertise, delivers advanced DNA damage analysis. Our proven track record in targeted therapeutics development ensures you gain critical insights for informed decision-making at every stage.

intodna icon 2

Services


Elevate your research outcomes with our end-to-end service tailored to your specific project requirements. We seamlessly integrate with your chosen biological model and multiplex our assays to harness the full potential of your research initiatives.

icon element 3

Mission


At intoDNA, our unwavering commitment is to deliver cutting-edge, innovative DNA damage diagnostics solutions wherever the integrity of DNA plays a critical role. We are the trusted partner for scientists seeking to unravel the intricacies of DNA damage and its far-reaching impacts.

Global Expertise

We support top pharmaceutical companies, small-to-mid-sized biotechs and research laboratories across the globe.

0.5K+

satisfied
scientists

100+

tested therapeutic
candidates

10K+

processed sample images over the last two years

8/10

partnered with 8 out of 10
top big pharma

0.5K+

satisfied
scientists

100+

tested therapeutic
candidates

10K+

processed sample images over the last two years

8/10

partnered with 8 out of 10
top big pharma
NEWSROOM

Latest News

decor
Dec 09, 2024

intoDNA awarded funding through the European Funds for Smart Economy (FENG) under the “Ścieżka SMART” program

intoDNA has been selected by the Polish Agency for Enterprise Development (PARP) to receive funding as part of European Funds for Smart Economy (FENG) under the "Ścieżka SMART" program. With this financing, intoDNA will pursue developing an innovative method to detect and measure replication stress directly within eukaryotic cells and tissues.
Dec 09, 2024

intoDNA awarded funding through the European Funds for Smart Economy (FENG) under the “Ścieżka SMART” program

Feb 07, 2024

Magda Kordon-Kiszala speaks about the shortcomings of γH2AX at the DDR Inhibitors Summit 2024

Nov 17, 2023

STRIDE validated in human in vivo samples in collaboration with AstraZeneca

image

Let’s talk about your project

Schedule a meeting with our scientific experts!